|
ORTHOFIX
INTERNATIONAL
N.V.
|
|
(Name
of Registrant as Specified in Its Charter)
|
|
RAMIUS
VALUE AND OPPORTUNITY MASTER FUND LTD
RAMIUS
ENTERPRISE MASTER FUND LTD
RAMIUS
ADVISORS, LLC
RCG
STARBOARD ADVISORS, LLC
RAMIUS
LLC
C4S
& CO., L.L.C.
PETER
A. COHEN
MORGAN
B. STARK
JEFFREY
M. SOLOMON
THOMAS
W. STRAUSS
J. MICHAEL
EGAN
PETER A.
FELD
STEVEN J.
LEE
CHARLES T.
ORSATTI
|
|
(Name
of Persons(s) Filing Proxy Statement, if Other Than the
Registrant)
|
|
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
calculated and state how it was
determined):
|
|
J.
Michael Egan
|
Mr.
Egan has served as the Chief Executive Officer of Steadman Hawkins
Research Foundation, an orthopedic research organization, since November
2006. From April 1996 through May 2004, Mr. Egan served as the
President and CEO of Bluebird Development, LLC, a financial partnership
with Kobayashi Pharmaceutical Company, an Osaka, Japan-based major
distributor of medical devices in Asia. Mr. Egan currently
serves on the Board of Cardica, Inc., a designer, manufacturer and
marketer of proprietary automated anastomotic systems used by surgeons to
perform coronary artery bypass surgery, and served as its Chairman from
August 2000 until January 2007. Mr. Egan also serves as the
Chairman of the Board of Directors at iBalance Medical, a privately held
medical device company, and is a director of several other privately held
companies.
|
|
Peter
A. Feld
|
Mr.
Feld is a Managing Director of Ramius LLC, a position he has held since
November 2008. Prior to becoming a Managing Director, Mr. Feld
served as a Director at Ramius LLC from February 2007 to November
2008. Mr. Feld joined Ramius LLC as an Associate in February
2005. From June 2001 to July 2004, Mr. Feld was an investment
banking analyst at Banc of America Securities, LLC, the investment banking
arm of Bank of America Corporation, a bank and financial holding
company. Mr. Feld currently serves on the Board of Directors of
CPI Corp. (NYSE: CPY), a leading portrait studio operator in North
America.
|
|
Steven
J. Lee
|
Mr.
Lee has served as the President of SL Consultant Inc., a private
investment firm and hedge fund specializing in growing companies in the
medical and high technology fields, since 2002. Mr. Lee was the
Founder, President, Chief Executive Officer and Chairman of PolyMedica
Corporation, a leading provider of diabetes care, from 1990 until August
2002, the time of his retirement from PolyMedica. Previously, Mr. Lee was
President and a director of Shawmut National Ventures. Prior to that, from
1984 to 1986, Mr. Lee served as President and Chief Executive Officer and
a director of RepliGen Corporation, a biotechnology company focused on the
development of novel therapeutics for neurological
disorders. Mr. Lee currently serves on the Board of Directors
of Kensey Nash Corporation (Nasdaq:KNSY), a medical device company known
for innovative product development and unique technology in the fields of
resorbable biomaterials used in a wide variety of medical procedures and
endovascular devices and Montreal, Maine & Atlantic Railway, a
railroad company with routes and operations in Maine, New Brunswick,
Quebec and Vermont, and on the Advisory Board of Capital Resource
Partners, an investment fund specializing in combined debt and equity
structures that provide creative financing alternatives for middle-market
firms.
|
|
Charles
T. Orsatti
|
Mr.
Orsatti has served as the Managing Partner of Fairfield Capital Partners,
Inc., a private equity fund with investments in securities, commercial
real estate and business equity investments, since 1995. From
1998 to 2004, he was the Managing Member of Orsatti and Partners, LLC
(formerly, J.P. Morgan Fairfield Partners, LLC), a private equity
firm. From 1995 to 1998, Mr. Orsatti was a senior consultant to
Chase Capital Partners (CCP), a predecessor of J.P. Morgan Partners, LLC.
He had previously served as an advisor and business consultant to CCP
since 1987. Until 1995, Mr. Orsatti was the Chairman and Chief
Executive Officer of Fairfield Medical Products Corporation, a worldwide
manufacturer of critical care products sold to hospitals and alternative
care facilities. Mr. Orsatti currently serves on the Board of
Directors of AngioDynamics, Inc. (Nasdaq:ANGO), a global provider of
solutions for musculoskeletal and vascular health specializing in
rehabilitation and regeneration products for the non-operative orthopedic,
spine and vascular markets and SRI Surgical Express, Inc. (Nasdaq:STRC), a
provider of operating room, supply chain and central sterilization
management solutions to hospitals and surgery centers across the United
States. Mr. Orsatti previously served as the Chairman of dj
Orthopedics, Inc., a global orthopedic sports medicine company
specializing in the design, manufacture and marketing of surgical and
non-surgical products and services that repair, regenerate and
rehabilitate soft tissue and bone, help protect against injury and treat
osteoarthritis of the knee, until shortly after its initial public
offering in 2001 and remained a Director until November 2007 when dj
Orthopedics was sold to affiliates of The Blackstone Group for $1.5
billion. Mr. Orsatti was also the managing partner responsible
for sourcing and executing the transaction that ultimately formed dj
Orthopedics in 1999. Mr. Orsatti has also held executive
positions with British Oxygen Corporation, Johnson & Johnson,
Coloplast, A/S Denmark and Air Products and Chemicals,
Inc.
|